Showing results (221-230 of 262) with videos related to

Sort By:
Pageof 27
Journal of Immunology (Baltimore, Md. : 1950)|December 19, 2014
Induction of potent CD8 T cell cytotoxicity by specific targeting of antigen to cross-presenting dendritic cells in vivo via murine or human XCR1Evelyn Hartung, Martina Becker, Annabell Bachem, et al.
Cancer Research|May 14, 2009
Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancerClaudia Geismann, Mascha Morscheck, Dorothee Koch, et al.
Physiological Reviews|June 16, 2017
Posttranslational Modification as a Critical Determinant of Cytoplasmic Innate Immune RecognitionPaul J Baker, Dominic De Nardo, Fiona Moghaddas, et al.
Nature Plants|February 12, 2020
Synchronization of developmental, molecular and metabolic aspects of source-sink interactionsAlisdair R Fernie, Christian W B Bachem, Yrjö Helariutta, et al.
Nature Genetics|September 29, 2020
Haplotype-resolved genome analyses of a heterozygous diploid potatoQian Zhou, Dié Tang, Wu Huang, et al.
The Journal of Experimental Medicine|May 19, 2010
Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cellsAnnabell Bachem, Steffen Güttler, Evelyn Hartung, et al.
European Journal of Psychotraumatology|April 30, 2024
Assessing complex PTSD and PTSD: validation of the German version of the International Trauma Interview (ITI)Rahel Bachem, Andreas Maercker, Yafit Levin, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|August 19, 2007
Oxidized low density lipoproteins induce apoptosis in human lymphocytes: involvement of mitogen-activated protein kinasesM Bustamante, F Díaz, M Muñoz, et al.
Thrombosis and Haemostasis|April 8, 2009
EMMPRIN (CD147) is a novel receptor for platelet GPVI and mediates platelet rolling via GPVI-EMMPRIN interactionPeter Seizer, Oliver Borst, Harald F Langer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 18, 2006
Effect of rosiglitazone treatment on plaque inflammation and collagen content in nondiabetic patients: data from a randomized placebo-controlled trialFranz Meisner, Daniel Walcher, Florence Gizard, et al.
Pageof 27